梅州双眼皮得要多少钱梅州白带拉丝带血,梅州安全的可视人工流产价格,梅州做一般打胎价格要多少钱,梅州妇产科做打胎一共多少钱,梅州怀孕多久做无痛人流效果好,梅州女子超导可视打胎价格,梅州妇科医院的地址

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

The United States and South Korea are expected to announce in the coming days that annual military exercises between the two nations are to be scaled back, according to a US defense official.The large-scale military exercises, known as Foal Eagle and Key Resolve, had been scheduled for this spring but according to the official, they will be scaled down to a small unit level and could involve virtual training.Defense officials say they can achieve the necessary training goals through the scaled-back exercises.The announcement is expected to come soon after President Donald Trump walked away from negotiations with North Korean leader Kim Jong Un in Vietnam.The US has already suspended several larger military exercises as part of an effort to ease tensions with North Korea following the last year's Singapore summit between the two leaders.In a news conference following last June's summit Trump called the exercises "provocative," stating, "It's inappropriate to be having war games."Trump has also questioned the usefulness of the exercises, citing the disproportionate share of the cost borne by the US.Former Defense Secretary James Mattis told reporters last November that the 2019 version of the Foal Eagle exercise was being "reorganized a bit" to keep from "being harmful to diplomacy."On Friday Defense Department officials refused to comment publicly about the status of the joint exercises but said they will proceed unless Trump specifically orders them canceled. "The (US-South Korean) alliance remains ironclad," said Pentagon spokesman Lt. Col. Dave Eastburn, when asked about the exercises. "Our forces maintain a high state of military readiness and vigilance in full support of a diplomatically led effort to bring peace, prosperity and stability to the Korean Peninsula."Earlier this month the US and South Korea reached a preliminary agreement on the cost of keeping nearly 30,000 troops in South Korea.Under the revised Special Measures Agreement, South Korea would boost its financial contribution to nearly billion, according to a State Department official and South Korean media. That's an increase from the roughly 0 million it had been paying per year during the previous five-year commitment.In an early February interview with CBS, Trump said he has "no plans" to withdraw US troops from South Korea and claimed to have "never even discussed removing them," but said "maybe someday" he would withdraw US forces from the country."I mean, who knows. But, you know, it's very expensive to keep troops there," Trump said, even though US military officials have said it is cheaper to house those troops in South Korea than in the US. 2682

The U.S. Food and Drug Administration has issued a warning to dog owners who feed Fido Darwin’s Natural Pet Food.According to the 142

The Senate likely now has enough votes to pass a measure blocking President Donald Trump's national emergency declaration after Sen. Rand Paul signaled his support for the resolution of disapproval."I can't vote to give extraconstitutional powers to the President," the Kentucky Republican said Saturday, according to the 334

The student at Marjory Stoneman Douglas High School in Parkland, Florida, who died by an apparent suicide on Saturday has been identified as 16-year-old Calvin Desir, according to police.Coral Springs Police Officer Tyler Reik confirmed the boy's identity on Wednesday. The circumstances surrounding the student's death are not clear. 346